This bill proposes extensive amendments to Minnesota's cannabis regulations, particularly concerning the sale of hemp-derived cannabinoids and medical cannabis provisions. A significant change is the replacement of the term "commissioner" with "office" in various sections of Minnesota Statutes, indicating a shift in oversight to the Office of Cannabis Management. The bill clarifies the roles of health care practitioners and medical cannabis manufacturers, establishes a patient registry, and sets requirements for manufacturers to supply medical cannabis. It also introduces limits on delta-9 tetrahydrocannabinol in edible products, emphasizes patient safety, and establishes a Cannabis Advisory Council to oversee these changes.

Additionally, the bill modifies the regulatory framework for medical cannabis manufacturers, allowing for telehealth certifications and removing certain registry participation requirements for practitioners. It introduces advertising restrictions for health care practitioners and enhances protections for patients in the registry program, prohibiting discrimination based on medical cannabis use. The legislation also establishes new licensing categories for lower-potency hemp edible manufacturers and retailers, outlines compliance requirements, and emphasizes consumer safety through labeling and packaging regulations. Overall, the bill aims to create a comprehensive and structured framework for cannabis and hemp regulation in Minnesota, ensuring patient access, safety, and compliance with state laws.

Statutes affected:
Introduction: 151.72, 342.01, 342.46
1st Engrossment: 152.22, 152.24, 152.25, 152.26, 152.261, 152.27, 152.28, 152.29, 152.31, 152.32, 152.33, 152.35, 152.37, 342.01, 342.02, 342.09, 342.51, 342.515, 342.52, 342.57, 342.59, 342.12, 342.14, 342.151, 342.17, 342.22, 342.28, 342.29, 342.30, 342.32, 342.33, 342.36, 342.37, 342.43, 342.61, 342.63, 151.72, 342.10, 342.11, 342.13, 342.18, 342.34, 342.39, 342.44, 342.45, 342.46, 342.62, 342.65, 342.66